This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Scripps Research Institute. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: Zaid Amso: Innovator in Peptide Conjugates for Diabetes Management
Introduction
Zaid Amso is a prominent inventor based in El Cajon, California. He has made significant contributions to the field of biomedical research, particularly in the development of innovative peptide conjugates aimed at managing blood glucose levels.
Latest Patents
Zaid Amso holds a patent for "Long-acting dual GIP/GLP-1 peptide conjugates and methods of use." This patent describes peptides and peptide conjugates that comprise a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. These peptides are designed for blood glucose management and can be utilized in treating conditions such as diabetes, obesity, non-alcoholic fatty liver disease (NAFLD), and non-alcoholic steatohepatitis (NASH).
Career Highlights
Zaid Amso is affiliated with The Scripps Research Institute, where he engages in cutting-edge research. His work focuses on the intersection of peptide chemistry and metabolic diseases, contributing to advancements in therapeutic strategies.
Collaborations
Throughout his career, Zaid has collaborated with notable researchers, including Weijun Shen and Peter G. Schultz. These collaborations have further enhanced the impact of his research in the scientific community.
Conclusion
Zaid Amso's innovative work in peptide conjugates represents a significant advancement in the management of diabetes and related conditions. His contributions continue to influence the field of biomedical research and offer hope for improved therapeutic options.